Barclays Maintains Equal-Weight on Exelixis, Raises Price Target to $49

Benzinga Newsdesk www.benzinga.com Positive 66.2%

Neg 0% Neu 0% Pos 66.2%

Barclays analyst Etzer Darout maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $45 to $49.